2010 Educational Workshop

Childhood Cancer Survivors –  Lessons Learned and Future Direction – 2010 Educational Workshop

Date: Wednesday, September 8, 2010
Time: 5:00 p.m. Registration and Dinner
6:00 to 8:30 p.m. Program
Place: Kapi‘olani Medical Center, Second Floor Auditorium
Who should attend: Parents, grandparents, relatives andcaregivers of a child who has had cancer, teachers, counselors, health professionals and anyone interested.

Keynote Speaker: Smita Bhatia, M.D., M.P.H.

You are cordially invited to attend a free educational workshop. Dinner and childcare will be provided. HCCF is excited and delighted to have with us Smita Bhatia, M.D., M.P.H., from City of Hope Comprehensive Cancer Center, Los Angeles, as our keynote speaker. Dr. Bhatia has done extensive work studying survivors of childhood Hodgkin?’s lymphoma and the late effects of bone marrow transplantation. She has also done quality of life research and the fruits of her work are still being used today to help childhood cancer
survivors. Additionally, Dr. Bhatia has led the Children?’s Oncology Group Late Effects Committee from 2000 to 2010. This workshop is made possible by a generous grant from NFL Charities. HCCF is grateful to NFL Charities for its continued support.


Dr. Bruce Shiramizu – Pediatric oncologist, Professor at John A. Burns School of Medicine in Pediatrics and Medicine, Affiliate faculty at Cancer Research Center of Hawaii, member of Children?’s Oncology Group. Dr. Shiramizu is studying the effects of chemotherapy on the brains of young children diagnosed with acute lymphocytic leukemia. He will discuss his current clinical trial and this exciting research he is conducting.

Dr. Andre Bachmann – Associate Professor at Cancer Research Center of Hawaii, Professor in the Dept. of Cell & Molecular Biology at John A. Burns School of Medicine, newly appointed Director/Department Chair of Pharmaceutical Sciences at the College of Pharmacy at UH Hilo. Dr. Bachmann has been studying neuroblastoma since 2001. He will discuss his very promising clinical trial to treat children who have relapsed with neuroblastoma.

Download the flyer and registration form.